pluripotent
/ ploor-IP-uh-tent /
Imagine a master craftsman who can build any room of a house — kitchen, bedroom, bathroom, every fixture inside — but does not build the scaffolding or the delivery trucks used during construction. Pluripotent cells are like that: they can become any cell type that makes up the body itself, but not the temporary support tissues, like the placenta, that surround and nourish an embryo.
Precisely, a pluripotent cell can give rise to cells of all three germ layers — ectoderm (skin and nerves), mesoderm (muscle, bone, blood), and endoderm (gut and lung linings) — and thus to essentially every tissue of the adult body. This sits one step below totipotency: pluripotent cells cannot, on their own, form the extraembryonic placenta. Embryonic stem cells are the classic example, and induced pluripotent stem cells are lab-made cells coaxed back to this state.
Pluripotency is the prize of much regenerative-medicine research, because in principle one pluripotent cell line could supply any cell type a patient needs. But the reality is hard: guiding pluripotent cells to a single pure, mature cell type is difficult, and leftover undifferentiated cells can form tumors called teratomas. So pluripotency is a powerful starting material, not a finished therapy, and most clinical work is still cautious and early-stage.
Researchers can take a pluripotent stem cell in a dish and, by adding the right sequence of signals over weeks, nudge it to become beating heart-muscle cells — a striking demonstration of pluripotency, though making them safe and pure enough for patients remains a challenge.
Pluripotency in action: one stem cell directed toward beating heart-muscle cells.
Pluripotent does not mean 'can make a whole new organism' — that is totipotency; pluripotent cells can build any body tissue but cannot form the placenta needed to sustain a pregnancy.